Mass Torts

May 11, 2026

Bard PowerPort Lawsuit

The Bard PowerPort (“BardPort”) is a port catheter device implanted just under the skin to allow for easy attachment to a catheter for the intravenous delivery of fluids or medication.

The Bard PowerPort has inherent design and manufacturing flaws that make the device prone to fracturing and migrating out of position. This can cause severe injuries, including internal vascular damage.

Individuals who suffered injuries due to a defective Bard PowerPort device are now bringing product liability lawsuits against the manufacturer of the PowerPort implants. Our firm is currently accepting new cases from anyone who had a Bard PowerPort port catheter device implanted and was injured due to a fracture, migration, or other implant failures.

May 5, 2026

Monsanto Roundup Lawsuit Update

by Ronald V. Miller, Jr.

In this post, our Roundup lawyers will give you:

An update on where things stand in the new $7.5 billion Roundup class action lawsuit settlement in May 2026
The likely direction the Roundup litigation will take moving forward, and

May 4, 2026

Paragard IUD Lawsuit Settlement Amounts

by Ronald V. Miller, Jr.

Our lawyers are handling Paragard IUD removal lawsuits in all 50 states. Over 3,500 women have filed a Paragard IUD lawsuit claiming that they were injured when a design defect in the IUD caused it to fracture during removal and leave foreign objects inside their bodies.

These lawsuits allege the Paragard intrauterine device breaks upon removal because it is made with inflexible plastic and degrades before the device expires. Over 3,000 lawsuits have been lodged against Teva Pharmaceutical and CooperSurgical by women who encountered issues such as breakage during removal or implantation, or other complications associated with the Paragard birth control device.

This page provides the latest update on the 2026 Paragard lawsuit. Our lawyers also speculate on the potential settlement value of a Paragard lawsuit if the litigation is resolved through a global settlement with the manufacturers. When could there be a settlement? Soon. These cases could be resolved by the end of 2026, with victims receiving payment in 2026 if the settlement is finalized quickly. Is that the most likely scenario? We are cautiously optimistic, but after the first trial loss in February 2026,

May 4, 2026

Hernia Mesh Lawsuit

by Ronald V. Miller, Jr.

Currently, thousands of hernia mesh lawsuits are pending in courts across the country. Our hernia mesh lawyers are handling these cases in all 50 states. This page:

Discusses this litigation
Provides the latest 2026 updates and the latest hernia mesh Bard MDL-2846 news 0n the settlement

May 2, 2026

Truvada Lawsuit

by Ronald V. Miller, Jr.

This page is about Truvada lawsuits and other HIV drug injury lawsuits involving kidney or bone injuries.

HIV drugs containing tenofovir disoproxil fumarate (TDF) are, we believe, putting patients at risk. This has resulted in HIV drug lawsuits from victims alleging kidney disease and failure, bone density loss, bone injuries, and other side effects.

Viread® and Truvada® are two of the first brand-name drugs developed by Gilead Sciences to treat HIV. Viread and Truvada both use tenofovir disoproxil fumarate (TDF), a new type of antiviral drug that was one of the first effective treatments for slowing HIV.

April 28, 2026

Paraquat Lawsuit Settlement Amounts

by Ronald V. Miller, Jr.

Our lawyers handle Paraquat lawsuits in all 50 states. This page provides the latest news and updates on Paraquat lawsuits in both state and federal courts. We also give our perspective on where this litigation is heading and provide projected settlement payouts for a viable Paraquat lawsuit. Continue reading

April 27, 2026

3M Earplug Lawsuit Update

by Ronald V. Miller, Jr.

This page provides the latest news and updates on the 3M earplug lawsuits and the settlement in 2024. We continue to update this page to provide information to victims, but you can find even more quality information from other plaintiffs in the over 10,000 comments below. We are not handling new 3M earplug lawsuits. Continue reading

April 26, 2026

Internal Bra Mesh Lawsuit

by Ronald V. Miller, Jr.

Thousands of women who underwent internal bra breast surgery are now experiencing serious complications from the surgical mesh placed inside them, and many are pursuing legal action against the manufacturers that promoted these products for a use the FDA never approved.

Breast mesh lawsuits allege that manufacturers of products such as AlloDerm, GalaFLEX, Phasix, and AlloMax marketed their devices for breast reconstruction, augmentation, and revision surgeries even though those applications had never been adequately studied or approved by the FDA. Patients were not warned. Surgeons were not given enough information. So when complications developed, including infection, mesh failure, chronic pain, and the need for additional surgery, most women did not have the information to connect the dots from their problems to the problems with the devices.

This page explains the internal bra mesh lawsuit in plain English: what the legal claims are, who may be eligible, what complications may qualify, and what these cases may be worth.

April 21, 2026

Dupixent Lawsuit for T-Cell Lymphoma

by Ronald V. Miller, Jr.

Dupixent (dupilumab) is a biologic medication used to treat atopic dermatitis, asthma, and other inflammatory conditions. It works by targeting specific immune pathways involved in allergic inflammation. For many patients with moderate to severe eczema, Dupixent has provided relief where topical medications failed. As a result, it has become one of the most widely prescribed biologic drugs for skin and respiratory conditions.

But for a growing number of patients, the experience with Dupixent has been very different. Over the past several years, doctors and researchers have reported cases in which patients treated with Dupixent were later diagnosed with cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma that primarily affects the skin. These reports have led to increasing scrutiny of whether Dupixent can worsen, accelerate, or mask CTCL in certain patients.

In many cases our lawyers are now investigating, patients who received Dupixent for newly diagnosed eczema and developed concerning symptoms within weeks or months, including swollen lymph nodes and worsening skin disease.

April 21, 2026

Zantac Lawsuit Update

by Ronald V. Miller, Jr.

Our attorneys also provide the latest updates on the Zantac class action lawsuit (including the disastrous news that the class action judge dismissed all federal court Zantac lawsuits). This page was updated on April 21, 2026.

Zantac Cancer Lawsuit Updates 2026

The Zantac litigation has been a rollercoaster, filled with major victories, setbacks, and unexpected twists. From the initial discovery of NDMA contamination to the collapse of certain cases and the resurgence of others, this litigation has taken many turns.